Theranostics
2012; 2(2):125-126.
doi:10.7150/thno.4129 This issueCite
Editorial
Protease Activity: Meeting Its Theranostic Potential
Seulki Lee1✉, Kwangmeyung Kim2✉
1. Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, USA 2. Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Korea
✉ Corresponding author: seulki.leegov, kimre.kr
Citation:
Lee S, Kim K. Protease Activity: Meeting Its Theranostic Potential. Theranostics 2012; 2(2):125-126. doi:10.7150/thno.4129. https://www.thno.org/v02p0125.htm
This themed issue provides up-to-date review and research articles covering the theranostic applications in the combined fields of protease research, diagnostics and drug development.
Keywords: Biomarkers, diagnosis, drug development, molecular imaging, proteases, theranostics
Citation styles
APA
Lee, S., Kim, K. (2012). Protease Activity: Meeting Its Theranostic Potential. Theranostics, 2(2), 125-126. https://doi.org/10.7150/thno.4129.
ACS
Lee, S.; Kim, K. Protease Activity: Meeting Its Theranostic Potential. Theranostics 2012, 2 (2), 125-126. DOI: 10.7150/thno.4129.
NLM
Lee S, Kim K. Protease Activity: Meeting Its Theranostic Potential. Theranostics 2012; 2(2):125-126. doi:10.7150/thno.4129. https://www.thno.org/v02p0125.htm
CSE
Lee S, Kim K. 2012. Protease Activity: Meeting Its Theranostic Potential. Theranostics. 2(2):125-126.